Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
Status:
Completed
Trial end date:
2019-09-10
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the efficacy and safety of a combined therapy using
thermotherapy (TT) (one session, 50 degrees Celsius for 30") + miltefosine at a standard dose
of 2.5 mg/kg/day for 21 days for the treatment of uncomplicated CL in Peru and Colombia